Cardiff Oncology, Inc.

Cardiff Oncology, Inc.verified

CRDF

Price:

$1.54

Market Cap:

$105.29M

Cardiff Oncology, Inc., a clinical-stage biotechnology firm located in San Diego, California, is dedicated to developing innovative medical treatments for cancer patients. Its lead therapeutic agent is onvansertib, an oral and selective inhibitor of Polo-like Kinase 1 (PLK1), which is being investigated for various anti-cancer applications, including clinical trials for metastatic colorectal cancer. The company's pipeline further includes CY140, an inhibitor targeting PLK1, PLK2, and PLK3, currently progressing through Phase 1/2 studies for both solid tumors and leukemias. Additionally, Cardiff Oncology is advancing TROV-054 in Phase 1b/2 trials, exploring its combination with FOLFIRI and be...[Read more]

Industry

Biotechnology

IPO Date

2004-07-27

Stock Exchange

NASDAQ

Ticker

CRDF

The ROE as of June 2026 (TTM) for Cardiff Oncology, Inc. (CRDF) is -95.50%

According to Cardiff Oncology, Inc.’s latest financial reports and current stock price. The company's current ROE is -95.50%. This represents a change of 288.47% compared to the average of -24.58% of the last 4 quarters.

Cardiff Oncology, Inc. (CRDF) Historical ROE (quarterly & annually)

How has CRDF ROE performed in the past?

The mean historical ROE of Cardiff Oncology, Inc. over the last ten years is -125.57%. The current -95.50% ROE has changed -23.95% with respect to the historical average. Over the past ten years (40 quarters), CRDF's ROE was at its highest in in the March 2021 quarter at -4.15%. The ROE was at its lowest in in the June 2017 quarter at -229.18%.

Quarterly (TTM)
Annual

Average

-125.57%

Median

-80.22%

Minimum

-382.83%

Maximum

-15.06%

Cardiff Oncology, Inc. (CRDF) ROE by Quarter and Year

Discovering the peaks and valleys of Cardiff Oncology, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 251.59%

Maximum Annual ROE = -15.06%

Minimum Annual Increase = -93.29%

Minimum Annual ROE = -382.83%

Quarterly (TTM)
Annual
YearROEChange
2025-101.02%84.44%
2024-54.77%-7.83%
2023-59.42%63.27%
2022-36.40%80.64%
2021-20.15%33.74%
2020-15.06%-93.29%
2019-224.50%37.53%
2018-163.24%-57.36%
2017-382.83%93.04%
2016-198.32%251.59%

Cardiff Oncology, Inc. (CRDF) Average ROE

How has CRDF ROE performed in the past?

The current ROE of Cardiff Oncology, Inc. (CRDF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-71.74%

5-year avg

-54.35%

10-year avg

-125.57%

Cardiff Oncology, Inc. (CRDF) ROE vs. Peers

How is CRDF’s ROE compared to its peers?

Cardiff Oncology, Inc.’s ROE is greater than Applied Therapeutics, Inc. (-65.63%), greater than Corbus Pharmaceuticals Holdings, Inc. (-70.89%), greater than Elicio Therapeutics, Inc. (-2748.16%), greater than Molecular Partners AG (-66.19%), greater than Forte Biosciences, Inc. (-106.16%), greater than PepGen Inc. (-59.89%), greater than Rani Therapeutics Holdings, Inc. (-245.45%), greater than Milestone Pharmaceuticals Inc. (-339.38%), greater than Cassava Sciences, Inc. (-99.85%), less than Innate Pharma S.A. (593.93%),

Build a custom stock screener for Cardiff Oncology, Inc. (CRDF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cardiff Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cardiff Oncology, Inc. (CRDF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cardiff Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Cardiff Oncology, Inc.'s ROE?

How is the ROE calculated for Cardiff Oncology, Inc. (CRDF)?

What is the highest ROE for Cardiff Oncology, Inc. (CRDF)?

What is the 3-year average ROE for Cardiff Oncology, Inc. (CRDF)?

What is the 5-year average ROE for Cardiff Oncology, Inc. (CRDF)?

How does the current ROE for Cardiff Oncology, Inc. (CRDF) compare to its historical average?